Collegium Pharmaceutical, Inc. (COLL) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 8 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for COLL is $58.00, representing a +62.7% upside from the current price of $35.64. Price targets range from a low of $56.00 to a high of $60.00.
